Boehringer Ingelheim (Group)

http://www.boehringer.com

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 143 affiliates in 47 countries and almost 37,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
In 2005, Boehringer Ingelheim posted net sales of 9.5 billion euro while spending almost one fifth of net sales in its largest business segment Prescription Medicines on research and development. *

	Start	1885-01-01 established
	Industry	pharmaceutical
	Person	Boehringer, Christian (Boehringer 201207 Chairman of Shareholders’ Committee)
	Person 2	Barner, Andreas (Boehringer)

	Region	Ingelheim
	Country	Germany
	Street	173 Binger Str.
	City	55216 Ingelheim
	Tel	+49-6132-770
		Address record changed: 2018-07-24

Basic data	Employees	I: 50,001 to 100,0 (2016-12-31)
	Currency	EUR
	Annual sales	17,498,000,000 (sales, net, consolidated (2018) 2018-12-31)
	Profit	2,075,000,000 (2018-12-31)
	Cash	4,303,000,000 (2018-12-31)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2019-10-30

More documents for Boehringer Ingelheim (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]